outcomes of patients with newly diagnosed crlf2-rearranged b-all
Published 2 years ago • 141 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
7:17
b-cell all with igh-il3 rearrangement and eosinophilia
-
8:57
outcomes of sct in t-all and t-lbl
-
2:20
the effect of ibrutinib dose-reduction on outcomes of patients with cll/sll: real-world evidence
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds
-
1:33
outcomes of reduced intensity allosct in patients with accelerated-phase myelofibrosis
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
2:24
comparing allosct outcomes in secondary and de-novo acute lymphoblastic leukemia
-
4:26
outcomes of ird in r/r multiple myeloma in routine clinical practice
-
7:28
1 year post hsct :)
-
10:59
10 month post hsct stem cell transplant
-
7:25
ai in hematology: advances, challenges, and future applications
-
6:02
predicting treatment outcomes in patients with r/r chl with ctdna and pet
-
1:16
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:36
the long-term outcomes of consolidative allosct for bpdcn
-
0:45
difference between quality of life & patient-reported outcomes
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
0:47
overview of the phase iii enhance trial schema
-
5:33
clinical utility of the homologous recombination deficiency score in aml & mds
-
1:12
patient-reported outcomes in hsct
-
1:44
the importance of patient-reported outcomes in clinical trials & clinical practice